通过与转录协调器LDB1的相互作用,LMO2促进AML的发展
Lihui Lu1,2, Jianwei Wang3, Fang Fang3
1Children's Hospital of Soochow University, Suzhou, 215003, China.
Cell death & disease
|August 12, 2023
概括
白血病研究显示,LDB1对于急性髓性白血病 (AML) 细胞存活和增殖至关重要. LMO2/LDB1复合体显示出作为AML治疗的治疗点的潜力.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 白血病涉及基因重组和过度表达,LMO2与T细胞癌症有关,AML的预后不佳.
- LDB1对于LMO2诱导的胸细胞转化至关重要,并稳定与白血病相关的蛋白质.
- 对于LMO2和LDB1在AML病变发生过程中的确切作用仍然不完全理解.
研究的目的:
- 研究LMO2和LDB1在急性髓性白血病 (AML) 的功能和机制.
- 评估LMO2淘汰对AML细胞增殖,生存和殖民地形成的影响.
主要方法:
- 在NB4,卡苏米-1和K562AML细胞系中,LMO2的基因被淘汰.
- 质谱和免疫沉以识别蛋白质复合体.
- 在体外和体外实验中评估LDB1的作用.
- 用于基因调节分析的RNA测序 (RNA-seq) 和染色体免疫沉测序 (ChIP-Seq).
主要成果:
- 在AML细胞系中确认了LMO2/LDB1蛋白质复合物的存在.
- 证明LDB1对AML细胞增殖和存活至关重要.
- 确定了LDB1作为细胞亡相关基因的调节者,包括LMO2.
- 观察到LMO2过度表达部分挽救了LDB1缺乏细胞中的增殖缺陷.
结论:
- 在AML中,LDB1作为瘤基因起作用,对细胞增殖和存活至关重要.
- LMO2/LDB1复合体代表了AML治疗的潜在治疗标.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Co-activators and Co-repressors
7.4K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Cooperative Binding of Transcription Regulators
6.5K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
6.5K
RNA Polymerase II Accessory Proteins
9.2K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.2K
General Transcription Factors
5.4K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.4K


